Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 2009

View Archived Issues

Reduced fractures with denosumab in postmenopausal women and men with prostate cancer

Studies with HC-056456 reveal CatSper channels as a target for blocking fertility

rAAV1-AAT gene therapy shows promise for future development in phase I trial

Doxorubicin derivative INNO-206 more potent than free doxorubicin in vivo

Merck & Co. to assess safety/efficacy of MK-2578 in kidney disease patients in phase II trial

Safety and efficacy of JTT-130 to be evaluated in obese type 2 diabetic patients

Bayer relegates clinical trials for alemtuzumab to Genzyme Japan

Bevacizumab plus erlotinib therapy shows activity in phase II clinical trial in HCC

Can-Fite BioPharma reports results from its phase II CF-101 trial in psoriasis

Opexa Therapeutics reports additional data with Tovaxin for multiple sclerosis

Novel PARP inhibitors presented by AstraZeneca for cancer therapy

R-Tech Ueno presents VAP-1 inhibitors for macular edema and other eye conditions

Akela undergoes corporate restructuring

PPARgamma agonists for the treatment of AD described by GlaxoSmithKline

Panacea Biotec discloses DPP-IV inhibitors for the treatment of type 2 diabetes

NeuroSearch patents novel dopamine and serotonin receptor ligands as antipsychotics

Luminex receives 510(k) clearance for new cystic fibrosis test

XenoPort reports results from a safety and tolerability trial of arbaclofen

LigoCyte initiates phase I/II study of nasally delivered dry powder norovirus vaccine

Shire provides update on velaglucerase alfa for Gaucher's disease

GlycoMimetics begins pilot study of GMI-1070 in sickle cell patients

Dor BioPharma receives NIH grant to support phase I/II DOR-201 trial in radiation enteritis

Evotec commences phase I trial of EVT-103

Ark Therapeutics receives feedback from MHRA on EG-013

Bayer Schering submits IND for phase I MN-IC trial, triggering milestone payments

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...